[…]
Publication Programs: Discovery Platform
SITC – 2024 – POSTER PRESENTATION 1092
Leveraging CRISPR/Cas9 and HDR to create an engineered CD33 CAR-T to treat AML […]
CRISPR-Based Therapy Analytical Development Summit – Oral Presentation
Analyzing Guide RNA (gRNA) Impurity Discovery & Quantification […]
Read More… from CRISPR-Based Therapy Analytical Development Summit – Oral Presentation
Immuno-Oncology Summit – 2024 – Poster Presentation P26
Purification of CAR+ T Cells Reveals Impact of Untransduced Cells in CAR-T Drug Product […]
Read More… from Immuno-Oncology Summit – 2024 – Poster Presentation P26
ASGCT – 2024 – Poster Presentation 1775
Gene-Edited Hematopoietic Stem Cells to Enable Next-Generation CAR-T Cell Therapy for the Treatment of AML […]
KEYSTONE SYMPOSIA – 2024 – POSTER PRESENTATION 1040
Uncovering Molecular and Functional Dynamics of Human Hematopoietic Stem Cells during In Vitro Culture for Cell Therapy Manufacturing […]
Read More… from KEYSTONE SYMPOSIA – 2024 – POSTER PRESENTATION 1040
Keystone Symposia – 2024 – Poster Presentation 2538
Leveraging CRISPR/Cas9 and HDR to create an engineered CD33 CAR-T to target AML […]
Read More… from Keystone Symposia – 2024 – Poster Presentation 2538
ASH – 2023 – POSTER PRESENTATION 3425
CD33-Deleted Hematopoietic Cells (Trem-Cel) Are Protected from CD33xCD3 Bispecific Antibody Treatment and Produce Significantly Reduced Levels of Inflammatory Cytokines in Preclinical Studies […]
ASH – 2023 – ORAL PRESENTATION 164
Multimodal Atlas of Paired Diagnosis and Relapse AML Samples Enables Novel Therapeutic Targeting of Surface Antigens […]